Document is current
Any future updates will be listed below
-
Authors
Nguyenla, Xammy
Wehri, Eddie
Van Dis, Erik
Biering, Scott B.
Yamashiro, Livia H.
Zhu, Chi
Stroumza, Julien
Dugast-Darzacq, Claire
Graham, Thomas G. W.
Wang, Xuanting
Jockusch, Steffen
Tao, Chuanjuan
Chien, Minchen
Xie, Wei
Patel, Dinshaw J.
Meyer, Cindy
Garzia, Aitor
Tuschl, Thomas
Russo, James J.
Ju, Jingyue
Näär, Anders M.
Stanley, Sarah
Schaletzky, Julia
-
Funding
Funding for this research was provided by:
Fastgrants
NSF (DGE-1752814)
Bowes Research Fellows Program (N7342, N7342)
Siebel Stem Cell Institute (W6188, W6188)
- License Information
-
More Information
Article History
Received: 30 June 2022
Accepted: 21 September 2022
First Online: 2 November 2022
Competing interests
: JS is inventor in a patent application on combination treatments for SARS-CoV-2, owned by the University of California. U.S. Patent Application Serial No. 63/053,208, entitled “COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS” relates to aspects of this work and was filed on July 17th, 2020. XN, EW, EVD, SBB, LY, CZ, JSt, CDD, TG, XW, SJ, CT, MC, WX, DP, CM, AG, TT, JJR, JJ, AN, SS declare no potential conflict of interest.
